Thromb Haemost 1981; 45(02): 142-145
DOI: 10.1055/s-0038-1650151
Original Article
Schattauer GmbH Stuttgart

Lithium Inhibits Adenylate Cyclase of Human Platelets

Leon Imandt
The Division of Haematology, Department of Internal Medicine, University of Nijmegen, Nijmegen, The Netherlands
,
Dorien Tijhuis
The Division of Haematology, Department of Internal Medicine, University of Nijmegen, Nijmegen, The Netherlands
,
Hans Wessels
The Division of Haematology, Department of Internal Medicine, University of Nijmegen, Nijmegen, The Netherlands
,
Clemens Haanen
The Division of Haematology, Department of Internal Medicine, University of Nijmegen, Nijmegen, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 22 September 1980

Accepted 20 January 1981

Publication Date:
05 July 2018 (online)

Summary

The ADP-induced aggregation of human platelets is markedly increased after preincubation with lithiumchloride, whereas lithium has the opposite effect on rabbit platelets. Since this phenomenon might be related to cAMP metabolism, the influence of lithium on total cAMP content and adenylate cyclase activity was investigated. Lithium does not significantly change the total cAMP content of human platelets neither during incubation nor during ADP-induced aggregation. Basal adenylate cyclase activity, however, was slightly inhibited by lithium in human platelets. The inhibition of adenylate cyclase by ADP appeared to be enhanced by lithium. Prostacyclin induced stimulation of adenylate cyclase is counteracted by this ion.

In rabbit platelets the prostacyclin stimulated adenylate cyclase activity is not affected by lithium.

These data suggest that a correlation exists between the influence of lithium on the aggregation of human and rabbit platelets and the sensitivity of their adenylate cyclase for this ion.

 
  • References

  • 1 Geerdink P, Levy-Toledano S, Wessels H, Caen J, Haanen C. Influence of lithium on aggregation, release-reaction and function of human platelets. Path Biol 1972; 20 (suppl) 15-27
  • 2 Imandt L, Genders T, Wessels H, Haanen C. The effect of lithium on platelet aggregation and platelet release reaction. Thromb Res 1977; 11: 297-308
  • 3 Imandt L, Tyhuis D, Wessels H, Haanen C. Observations on ADP aggregation of lithium-chloride incubated platelets in a variety of mammalian species. Haemostasis 1980; 9: 276-287
  • 4 Anderson ER, Foulks JG. Competitive inhibition by lithium and hydrogen ion of the effect of calcium on the aggregation of rabbit platelets. Thromb Haemostas 1976; 36: 343-359
  • 5 Forn J, Lithium and cyclic AMP. In: Lithium Research and Therapy. Ed, Johnson FN. Academic Press; London: 1975. page 485-497
  • 6 Murphy DL, Donnelly C, Moskowitz J. Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets. Clin Pharmacol Ther 1973; 14: 810-814
  • 7 Wang YC, Pandey GN, Mendels J, Frazer A. Effect of lithium on prostaglandin E1-stimulated adenylate cyclase activity of human platelets. Bioch Pharm 1974; 23: 845-855
  • 8 Salzman EW. Cyclic AMP and platelet function. N Engl J Med 1972; 286: 358-363
  • 9 Mills DC B, MacFarlane DE. Platelet receptors. In: Platelets in Biology and Pathology. Ed Gordon JL. North-Holland Publ Comp Amsterdam; 1976. page 159-202
  • 10 Barber AJ. Cyclic nucleotides and platelet aggregation. Effects of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes. Biochim Biophys Acta 1976; 444: 579-595
  • 11 McDonald JWD, Stuart RK. Regulation of cyclic AMP levels and aggregation in human platelets by prostaglandin E1 . J Lab Clin Med 1973; 81: 838-849
  • 12 Cole B, Robinson A, Hartman RC. Studies on the role of cyclic AMP in platelet function. Ann N Y Acad Sci 1971; 185: 477-487
  • 13 Salzman EW, Kensler PC, Levine L. Cyclic 3’, 5’-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic AMP in platelet function. Ann N Y Ac Sci 1972; 201: 61-71
  • 14 Salzman EW, Neri LL. Cyclic 3’, 5’-adenosine monophosphate in human blood platelets. Nature 1969; 224: 609-610
  • 15 Salzman EW, Lindon JN, Rodvin R. Cyclic AMP in human blood platelets: Relation to platelet prostaglandin synthesis induced by centrifugation or surface contact. J Cyclic Nucleotide Res 1976; 2: 25-37
  • 16 Haslam RJ. Roles of cyclic nucleotides in platelet function. In: Biochemistry and Pharmacology of Platelets. CIBA Foundation Symposium 35, Elsevier; Amsterdam: 1975. page 121-151
  • 17 Cooper DMF, Rodbell M. ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase. Nature 1979; 282: 517-518
  • 18 Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-665
  • 19 Imandt L, Genders T, Wessels H, Haanen C. An improved method for preparing platelet-rich plasma. Thromb Res 1977; 11: 429-432
  • 20 Brown RL, Albano JDM, Ekins RP, Sghuzi AM, Tampion W. A simple and sensitive saturation assay method for the measurement of adenosine 3’-5’-cyclic monophosphate. Biochem J 1971; 121: 561-562
  • 21 Haslam RJ, Taylor A. Effects of catecholamines on the formation of adenosine 3’-5’-cyclic monophosphate in human blood platelets. Biochem J 1971; 125: 377-379
  • 22 Haslam RJ, McClenaghan MC. Effects of collagen and aspirin on the concentration of guanosine 3’-5’-cyclic monophosphate in human blood platelets: Measurement by a prelabeling technique. Biochem J 1974; 138: 317-320
  • 23 Best LC, Martin TJ, Russell RG G, Preston FE. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Nature 1977; 267: 850-852
  • 24 Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12: 897-913
  • 25 Wessels JMC, Haanen C. Influence of lithium on function, metabolism and membrane properties of blood platelets. Excerpta Med 1975; 357: 192-198
  • 26 Dechavanne M, Lagarde M. Mise en évidence de deux compartiments d’AMP cyclique dans des suspensions de plaquettes humaines. Path Biol 1974; (suppl) 22: 17-21
  • 27 Moncada S, Vane JR, Whittle BJ R. Relative potency of prostacyclin, prostaglandin E1 and D1 as inhibitors of platelet aggregation in several species. J Physiol (Lond) 1977; 273: 2P-4P
  • 28 Gorman RR, Bunting S, Miller OV. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 1977; 13: 377-388
  • 29 Tateson JE, Moncada S, Vane JR. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 1977; 13: 389-397
  • 30 Birch NJ. The role of magnesium and calcium in the pharmacology of lithium. Biol Psychol 1973; 7: 269-272
  • 31 Birch NJ. Lithium and magnesium dependent processes. Lancet I. 1975: 1384
  • 32 Haslam RJ, Davidson MML, Fox JEB, Lynman JA. Cyclic nucleotides in platelet function. Thromb Haemostas 1978; 40: 232-240
  • 33 Salzman EW, MacIntyre DE, Steer ML, Gordon JL. Effect on platelet activity of inhibition of adenylate cyclase. Thromb Res 1978; 13: 1089-1101